The size of the European Sleep Apnea Devices Market is estimated to value USD 2.06 Billion in 2022 and USD 2.34 Billion by 2027, growing at a CAGR of 2.57% from 2022 to 2027. It captures 25% of the global market share.
In Europe, government authorities are taking initial steps to enhance healthcare services and with advanced sleep labs and sleep tests and therapies, fuelling the growth of the sleep apnea devices market in the region. The number of people suffering from OSA is continuously rising. The problem is highly prevalent in the urban population, leading to a constant rise in demand for sleep apnea devices. The continually increasing population affected by sleeping disorders in this region is propelling the growth rate of the sleep apnea devices market in Europe.
Growing incidences of unhealthy sleeping habits among many individuals due to work stress and over usage of smartphones at night, especially people between the ages of 15 to 30, is anticipated to boost up the demand of the market and increase growth opportunities for the key players in the Europe sleep apnea devices market. Furthermore, increasing focus on initiatives from private and public organizations for developing innovative sleep apnea therapies and devices is expected to create growth opportunities for the sleep apnea devices market in Europe. Furthermore, rapid advancements of Smartphones which are developed and integrated with sensors, are supposed to provide lucrative growth opportunities for the European sleep apnea devices market in this area during the forecast period.
High costs associated with technologically advanced sleep apnea devices like CPAP are expected to slow down the growth rate of the sleep apnea devices market in Europe during the forecast period. Furthermore, the masks used for therapies are causing claustrophobia or discomfort to patients. The risks associated with sleep apnea are the significant challenges posed to the key market players functioning in the European sleep apnea devices market.
This research report on the Europe Sleep Apnea Devices Market has been segmented and sub-segmented into the following categories:
By Diagnostic Devices:
By Therapeutic Devices:
Regionally, the UK sleep apnea devices market is expected to dominate the European market during the forecast period and is likely to contribute the most substantial share. The factors that are strongly contributing to the growth of the UK’s market are the increasing incidence of obesity population, the rise in demand for sleep apnea devices owing to the high prevalence of OSA in this region, increasing adoption rate of polysomnography, and positive air pressure therapies.
KEY MARKET PLAYERS:
A few of the notable companies operating in the European sleep apnea devices market profiled in this report are ResMed, Inc. (U.S.), Philips Healthcare (Netherlands), and Fisher & Paykel Healthcare Ltd. (New Zealand). Other players in the market include SomnoMed Ltd. (Australia), Compumedics Limited (Australia), Weinmann Medical Devices GmbH (Germany), and Whole You, Inc. (U.S.).
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com